Literature DB >> 2949676

Epidural and subcutaneous morphine, meperidine (pethidine), fentanyl and sufentanil in the rat: analgesia and other in vivo pharmacologic effects.

R H van den Hoogen, F C Colpaert.   

Abstract

The experiments examined the characteristics of analgesia produced by different doses of morphine, meperidine (pethidine), fentanyl, and sufentanil after epidural and subcutaneous injection in rats. The specificity of the analgesia was also determined; other in vivo pharmacologic activities (i.e., blockade of pinna and cornea reflexes and production of skeletal muscle rigidity) were monitored as pharmacologic indices of opiate drug activity in the brain. After subcutaneous injection, the opiates produced dose-dependent analgesia, blocked the pinna and cornea reflexes, and induced muscle rigidity. After epidural injection, all four compounds produced dose-dependent analgesia and had greater potency, earlier onset, shorter duration, and greater specificity of analgesic action than was the case after subcutaneous injection. Specificity is defined here as the ratio of the ED50 dose that blocked the pinna reflex to the ED50 dose that produced analgesia. The gains in potency and specificity, but not the gains in onset time and the losses in duration of analgesia, differed considerably among the compounds that were examined. The subcutaneous-to-epidural potency ratio related in a linear manner with the lipid-to-water partition coefficient. The gain in specificity also appeared to be related to lipid solubility. The microgram X kg-1 doses at which the opiates produced analgesia in rats correlate well with the potency of these compounds in producing analgesia after epidural injection in humans. The rat epidural preparation reflected the doses, onset, and specificity, but not the duration, of analgesia produced by epidural opiates in humans.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2949676     DOI: 10.1097/00000542-198702000-00013

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  13 in total

Review 1.  Pharmacotherapy of opioids: present and future developments.

Authors:  T F Meert
Journal:  Pharm World Sci       Date:  1996-01

2.  Opiate states of memory: receptor mechanisms.

Authors:  L A Bruins Slot; F C Colpaert
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

3.  Is morphine dependence mediated exclusively by the Mu receptor?

Authors:  R E Adams; G F Wooten
Journal:  Neurochem Res       Date:  1993-10       Impact factor: 3.996

Review 4.  Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment.

Authors:  Sandra D Comer; Catherine M Cahill
Journal:  Neurosci Biobehav Rev       Date:  2018-12-05       Impact factor: 8.989

5.  Reinforcing effects of fentanyl and sufentanil aerosol puffs in rats.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Psychopharmacology (Berl)       Date:  2022-04-15       Impact factor: 4.415

6.  Regional cerebral glucose utilization in withdrawal following systemic and intracerebroventricular sufentanil administration.

Authors:  R E Adams; G F Wooten
Journal:  Neurochem Res       Date:  1994-10       Impact factor: 3.996

Review 7.  Current methods of controlling post-operative pain.

Authors:  R S Sinatra
Journal:  Yale J Biol Med       Date:  1991 Jul-Aug

8.  Effects of fentanyl on pain and motor behaviors following a collagenase-induced intracerebral hemorrhage in rats.

Authors:  Laurence Saine; Pierre Hélie; Pascal Vachon
Journal:  J Pain Res       Date:  2016-11-15       Impact factor: 3.133

9.  In search of a rodent model of placebo analgesia in chronic orofacial neuropathic pain.

Authors:  Titilola Akintola; Christina Tricou; Charles Raver; Alberto Castro; Luana Colloca; Asaf Keller
Journal:  Neurobiol Pain       Date:  2019-05-14

10.  The grimace scale reliably assesses chronic pain in a rodent model of trigeminal neuropathic pain.

Authors:  Titilola Akintola; Charles Raver; Paige Studlack; Olivia Uddin; Radi Masri; Asaf Keller
Journal:  Neurobiol Pain       Date:  2017-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.